TWI326684B - - Google Patents
Download PDFInfo
- Publication number
- TWI326684B TWI326684B TW093104774A TW93104774A TWI326684B TW I326684 B TWI326684 B TW I326684B TW 093104774 A TW093104774 A TW 093104774A TW 93104774 A TW93104774 A TW 93104774A TW I326684 B TWI326684 B TW I326684B
- Authority
- TW
- Taiwan
- Prior art keywords
- irinotecan hydrochloride
- crystal
- type crystal
- irinotecan
- hydrochloride
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/22—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains four or more hetero rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/4738—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems
- A61K31/4745—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems condensed with ring systems having nitrogen as a ring hetero atom, e.g. phenantrolines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Steroid Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2003046908 | 2003-02-25 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| TW200508239A TW200508239A (en) | 2005-03-01 |
| TWI326684B true TWI326684B (US07521420-20090421-C00691.png) | 2010-07-01 |
Family
ID=32923248
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| TW093104774A TW200508239A (en) | 2003-02-25 | 2004-02-25 | Method for preparing polymorphism of irinotecan hydrochloride |
Country Status (12)
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20060046993A1 (en) * | 2004-09-01 | 2006-03-02 | Pharmacia Italia S.P.A. | Crystalline polymorphic form of irinotecan hydrochloride |
| US7897772B2 (en) * | 2004-10-01 | 2011-03-01 | Kabushiki Kaisha Yakult Honsha | Acid addition salt of irinotecan |
| EP2082741A1 (en) | 2005-09-20 | 2009-07-29 | Scinopharm Singapore Pte, Ltd. | Novel crystal form of irinotecan hydrochloride |
| CN101318964B (zh) * | 2007-06-07 | 2010-12-15 | 上海迪赛诺医药发展有限公司 | 盐酸伊立替康新晶型及其制备方法 |
| US7572803B2 (en) * | 2007-10-25 | 2009-08-11 | The Christus Stehlin Foundation For Cancer Research | Hydrated crystalline esters of camptothecin |
| IT1391757B1 (it) * | 2008-11-11 | 2012-01-27 | Antibioticos Spa | Irinotecan cloridrato cristallino e metodi per la sua preparazione |
| CN102311443B (zh) * | 2011-08-24 | 2014-07-16 | 上海北卡医药技术有限公司 | 盐酸伊立替康的新晶型及其制备方法 |
| CN102617584B (zh) * | 2012-03-14 | 2013-10-16 | 海南锦瑞制药股份有限公司 | 一种盐酸伊立替康化合物及其药物组合物 |
| CN111100135A (zh) * | 2019-10-24 | 2020-05-05 | 连云港杰瑞药业有限公司 | 一种盐酸伊立替康的精制方法 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS6247193A (ja) | 1985-08-26 | 1987-02-28 | 内橋エステック株式会社 | 電子部品のはんだ付方法 |
| JPH034077A (ja) | 1989-05-30 | 1991-01-10 | Nissho Corp | 逆止弁 |
| JPH07277981A (ja) | 1994-04-12 | 1995-10-24 | Yakult Honsha Co Ltd | 徐放性抗腫瘍製剤 |
| JPH1017472A (ja) | 1996-07-04 | 1998-01-20 | Yakult Honsha Co Ltd | 徐放性抗腫瘍製剤 |
| IL163820A0 (en) * | 2002-03-01 | 2005-12-18 | Pharmacia Italia Spa | Crystalline polymorphic form of irinotecan hydrochloride |
-
2004
- 2004-02-24 JP JP2005502882A patent/JP4566128B2/ja not_active Expired - Fee Related
- 2004-02-24 WO PCT/JP2004/002126 patent/WO2004076460A1/ja active Application Filing
- 2004-02-24 NZ NZ541990A patent/NZ541990A/en not_active IP Right Cessation
- 2004-02-24 AU AU2004215560A patent/AU2004215560B2/en not_active Ceased
- 2004-02-24 CN CNB2004800047816A patent/CN100418970C/zh not_active Expired - Fee Related
- 2004-02-24 US US10/546,687 patent/US7488825B2/en not_active Expired - Fee Related
- 2004-02-24 BR BRPI0407791-1A patent/BRPI0407791A/pt not_active IP Right Cessation
- 2004-02-24 KR KR1020057014560A patent/KR101095382B1/ko not_active IP Right Cessation
- 2004-02-24 CA CA2516643A patent/CA2516643C/en not_active Expired - Fee Related
- 2004-02-24 EP EP04714012A patent/EP1598356A4/en not_active Withdrawn
- 2004-02-25 TW TW093104774A patent/TW200508239A/zh not_active IP Right Cessation
-
2005
- 2005-08-18 IL IL170350A patent/IL170350A/en not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| BRPI0407791A (pt) | 2006-02-14 |
| CA2516643C (en) | 2011-04-19 |
| JP4566128B2 (ja) | 2010-10-20 |
| US7488825B2 (en) | 2009-02-10 |
| CA2516643A1 (en) | 2004-09-10 |
| KR20050100661A (ko) | 2005-10-19 |
| KR101095382B1 (ko) | 2011-12-16 |
| WO2004076460A1 (ja) | 2004-09-10 |
| AU2004215560A1 (en) | 2004-09-10 |
| EP1598356A1 (en) | 2005-11-23 |
| NZ541990A (en) | 2009-04-30 |
| CN1751048A (zh) | 2006-03-22 |
| CN100418970C (zh) | 2008-09-17 |
| EP1598356A4 (en) | 2008-07-02 |
| US20060234904A1 (en) | 2006-10-19 |
| JPWO2004076460A1 (ja) | 2006-06-01 |
| AU2004215560B2 (en) | 2009-09-24 |
| IL170350A (en) | 2010-11-30 |
| TW200508239A (en) | 2005-03-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US9340565B2 (en) | Crystalline forms | |
| US8236834B2 (en) | Crystalline forms of thiazolidinedione compound and its manufacturing method | |
| US10793536B2 (en) | Vortioxetine pamoic acid salt and crystal form thereof | |
| TWI699367B (zh) | 用於製備丁基原啡因之方法 | |
| TWI326684B (US07521420-20090421-C00691.png) | ||
| US10793521B2 (en) | Crystalline form II of dextral oxiracetam, preparation method therefor and use thereof | |
| WO2007082471A1 (en) | Anti-infective compound, preparation method thereof and use thereof | |
| JP2021523880A (ja) | ジヒドロピリミジン化合物の固体形態及びその調製方法及びその使用 | |
| WO2013041435A1 (en) | Compressed oral dosage form for asenapine maleate | |
| JP4829120B2 (ja) | イリノテカン酸付加塩 | |
| CN103006648A (zh) | 一种马来酸左旋氨氯地平药物活性组合物及其制备方法 | |
| JP5718811B2 (ja) | 経口液剤 | |
| CN105399725B (zh) | 曲格列汀化合物其盐、晶体、药物组合物和用途 | |
| WO2007082472A1 (en) | Anti-infective quinolone compound, preparation method thereof and use thereof | |
| CN103450311B (zh) | 维库溴铵的晶型及其制备方法和用途 | |
| CN1498219A (zh) | 多晶型的N-(2,3-二甲基-5,6,7,8-四氢呋喃并[2,3-b]喹啉-4-基)-2-(2-氧代吡咯烷-1-基)乙酰胺 | |
| CN117137921A (zh) | 一种ARNi复合物的药物组合物的新应用 | |
| CN116813541A (zh) | 米力农药用共晶体及其制备方法 | |
| WO2018090360A1 (zh) | 一种三芳基二甲基哌嗪二盐酸盐的多晶型物及其制备方法和应用 | |
| CN117137913A (zh) | 一种ARNi复合物与氨氯地平的复方药物组合物的新应用 | |
| JP5608666B2 (ja) | ２種のピノセンブリン、その製造方法、および、医薬組成物の製造におけるその使用 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MM4A | Annulment or lapse of patent due to non-payment of fees |